FHA
PBYI icon

First Horizon Advisors’s Puma Biotechnology PBYI Stock Holding History

First Horizon Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3
Closed – – 1474
2015
Q1 		$0 Hold
3
– – ﹤0.01% 1546
2014
Q4 		$0 Buy
+3
New +$666 ﹤0.01% 1541

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Horizon Advisors's PBYI Position: Q2 2015 in Review

First Horizon Advisors sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 3 shares.

First Horizon Advisors first reported a position in PBYI in Q4 2014 and held it in 2 quarters. The position peaked at $0 in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • First Horizon Advisors reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • First Horizon Advisors sold 3 Puma Biotechnology shares in Q2 2015.
  • First Horizon Advisors first reported a position in Puma Biotechnology in Q4 2014 and held it in 2 quarters.
  • First Horizon Advisors's Puma Biotechnology position peaked at $0 in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on First Horizon Advisors's 13F filing for Q2 2015, filed 31 Jul 2015.